This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Donor | Donee | Amount (current USD) | Donation date | Cause area | URL | Notes |
|---|---|---|---|---|---|---|
| Effective Altruism Funds: Global Health and Development Fund | Instiglio | 60,000.00 | Global health | https://app.effectivealtruism.org/funds/global-development/payouts/1qrRBknrSXGe4825arATUb | Donation process: GiveWell found an interesting donation opportunity with Instiglio that fit into GiveWell Incubation Grants and would normally be funded by Good Ventures. Since this is a more high-risk high-reward grant than typical for GiveWell Incubation Grants, they decided to use funds from the Global Health and Development Fund rather than request money from Good Ventures Intended use of funds (category): Direct project expenses Intended use of funds: The grant is intended to cover a portion of the design costs for the initial technical specification of a new Health Outcomes Fund, intended to be between $50 million and $100 million, focused on primary health care. Partners working with Instiglio and likely contirbutors to the fund include GiveWell, UBS Optimus, and the Global Fund to Fight AIDS, Tuberculosis and Malaria. The fund should allow funders in global health and development to fund programs based on results, while reducing the transaction costs of a typical results-based contract. Design decisions include metric pricing, the selection of implementers and payment metrics, and verification and evaluation methodologies. Donor reason for selecting the donee: GiveWell has four reason to recommend donating to the fund: (1) GiveWell can help push the fund to adopt its values of cost-effectiveness and transparency. (2) Participating in the fund may lead GiveWell to work with and influence international aid agencies toward GiveWell's approach. (3) GiveWell may also learn and update its approach from working with the other agencies. (4) The result-based financing method being tried by this fund may be worthwhile. Reservations include (a) Skepticism of some arguments for results-based financing. (b) Uncertainty about whether GiveWell will contribute to the fund after initial scoping. (c) Lower cost-effectiveness than the top GiveWell-recommended charities. The reason for funding through EA Funds rather than Good Ventures is the greater risk and reward, making it more suited for the fund Donor reason for donating that amount (rather than a bigger or smaller amount): Likely a sufficient amount for this initial phase of scoping. No explicit amount-related discussions are included Percentage of total donor spend in the corresponding batch of donations: 100.00% Donor reason for donating at this time (rather than earlier or later): Likely determined by the stage of the fund Donor thoughts on making further donations to the donee: GiveWell writes: "We are uncertain whether we will contribute funding to the Outcomes Fund once the scope is finalized. We would guess that there is sufficient alignment between partners to co-design a fund which meets our minimum criteria for cost-effectiveness, but we are uncertain whether this is the case." Other notes: The grant is also listed under GiveWell Incubation Grants and has a page there: https://www.givewell.org/research/incubation-grants/april-2019-instiglio. |
|
| Effective Altruism Funds: Global Health and Development Fund | Malaria Consortium | 1,705,000.00 | Global health/malaria | https://app.effectivealtruism.org/funds/global-development/payouts/659BJJ1NQSu4xWdZvjE1bB | Donation process: GiveWell looked at the funding gap and value of marginal funds for each of its top charities. Two charities that competed closely for the discretionary regrant were Malaria Consortium and Against Malaria Foundation. The blog post https://blog.givewell.org/2019/03/29/allocation-of-discretionary-funds-from-q4-2018/ has a lengthy section "Comparing Malaria Consortium and AMF" that applies the six principles in https://blog.givewell.org/2018/11/26/our-recommendation-to-good-ventures/#Principles to compare the two options, ultimately deciding on allocating 100% to Malaria Consortium. The funds held by the Effective Altruism Global Health and Development Fund were also granted to Malaria Consortium. There was discussion of holding funds for work investigating opportunities in public health regulation https://blog.givewell.org/2019/02/07/how-givewells-research-is-evolving/ but ultimately, the grant investigators decided to grant all the money to Malaria Consortium Intended use of funds (category): Direct project expenses Intended use of funds: Malaria Consortium expects to use the funding (earmarked for seasonal malaria chemoprevention) on these projects, in decreasing order of priority: (1) Contribute to filling a potential funding gap in Burkina Faso, (2) Scale up further in Nigeria and Chad in 2020, (3) Fund the continuation of programs into 2021. Donor reason for selecting the donee: Malaria Consortium is operating in a domain, seasonal malaria chemprevention, that GiveWell considers highly cost-effective, and is estimated at delivering 8.3x as much value per unit money as cash transfers. Reasons for selecting Malaria Consortium over the Against Malaria Foundation include: stronger organizational management at Malaria Consortium, and more cooperation from Malaria Consortium in helping with GiveWell's evaluation process Donor reason for donating that amount (rather than a bigger or smaller amount): The amount of $1.705 million is based on the funds available in the Effective Altruism Global Health and Development Fund. This money is on top of the $8.4 million being directly regranted by GiveWell Percentage of total donor spend in the corresponding batch of donations: 100.00% Donor reason for donating at this time (rather than earlier or later): This discretionary regrant is done every quarter, for the completed quarter. This particular grant is for Q4 2018 (September to December) and would therefore be expected to be in Q1 2019. Also, grants from the EA Global Health and Development Fund are supposed to be made in March, which probably explains the timing Other notes: The reasoning for the allocation is described in detail in the blog post https://blog.givewell.org/2019/03/29/allocation-of-discretionary-funds-from-q4-2018/ (published 2019-03-29). Affected countries: Burkina Faso|Nigeria|Chad. |
|
| Effective Altruism Funds: Global Health and Development Fund | Schistosomiasis Control Initiative | 1,500,000.00 | Global health/deworming | https://app.effectivealtruism.org/funds/global-development/payouts/6os9pZr9kcMaCgmMiUwMcU | Grant made for the same reasons as the GiveWell discretionary regrant https://blog.givewell.org/2018/04/06/allocation-of-discretionary-funds-from-q4-2017/ made concurrently. Percentage of total donor spend in the corresponding batch of donations: 100.00%. | |
| Effective Altruism Funds: Global Health and Development Fund | No Lean Season | 150,000.00 | Seasonal intracountry migration | https://app.effectivealtruism.org/funds/global-development/payouts/3xW9fK4U7YqMsKaQgGG8So | Elie Hassenfeld recommended No Lean Season on 2017-09-27 after receiving a phone call from Karen Levy saying that No Lean Season had failed to raise funds to meet the unexpectedly high demand for money from borrowers. Hassenfeld recommended the grant amount because Levy told him that would enable the program to continue operating uninterrupted. This was before No Lean Season became a GiveWell top charity. Affected countries: Bangladesh; Percentage of total donor spend in the corresponding batch of donations: 100.00%. | |
| Effective Altruism Funds: Global Health and Development Fund | Against Malaria Foundation | 331,126.00 | Global health/malaria | https://app.effectivealtruism.org/funds/global-development/payouts/5usCuBFHQk2UcQ0WYOIUEk | Grant discussed at http://effective-altruism.com/ea/19d/update_on_effective_altruism_funds/ along with reasoning, though the amount at the time was not the full amount (just $311,562). Grant to AMF because Hassenfeld believes it is the highest expected value opportunity in the domain. Also, all funding opportunities in GiveWell Incubation Grants have been fully met to his satisfaction, so no need to use this fund for that money. Hassenfeld is allocating the money immediately as he does not expect the situation to change over the next six months. Percentage of total donor spend in the corresponding batch of donations: 100.00%. |
| Donee | Donors influenced | Cause area | Metadata | Total | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Malaria Consortium | Effective Altruism Funds: Global Health and Development Fund (filter this donor) | Global health/malaria | FB Tw WP Site GW | 1,705,000.00 | 1,705,000.00 | 0.00 | 0.00 |
| Schistosomiasis Control Initiative | Effective Altruism Funds: Global Health and Development Fund (filter this donor) | Global health/deworming | Tw WP Site GW | 1,500,000.00 | 0.00 | 1,500,000.00 | 0.00 |
| Against Malaria Foundation | Effective Altruism Funds: Global Health and Development Fund (filter this donor) | Global health/malaria | FB Tw WP Site GW CN GS TW | 331,126.00 | 0.00 | 0.00 | 331,126.00 |
| No Lean Season | Effective Altruism Funds: Global Health and Development Fund (filter this donor) | 150,000.00 | 0.00 | 0.00 | 150,000.00 | ||
| Instiglio | Effective Altruism Funds: Global Health and Development Fund (filter this donor) | 60,000.00 | 60,000.00 | 0.00 | 0.00 | ||
| Total | -- | -- | -- | 3,746,126.00 | 1,765,000.00 | 1,500,000.00 | 481,126.00 |
Graph of spending by donee and year (incremental, not cumulative)
Graph of spending by donee and year (cumulative)
| Donor | Donees | Total | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Effective Altruism Funds: Global Health and Development Fund (filter this donee) | Against Malaria Foundation (filter this donee), Instiglio (filter this donee), Malaria Consortium (filter this donee), No Lean Season (filter this donee), Schistosomiasis Control Initiative (filter this donee) | 3,746,126.00 | 1,765,000.00 | 1,500,000.00 | 481,126.00 |
| Total | -- | 3,746,126.00 | 1,765,000.00 | 1,500,000.00 | 481,126.00 |
Graph of spending by donee and year (incremental, not cumulative)
Graph of spending by donee and year (cumulative)
